Clinical Trials Browser

Phase 1/2 × Papillomavirus Infections × Clear all

NCT07578467 2026-05-11

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

Phase 1/2 Not yet recruiting

Carcinoma, Squamous Cell, Papillomavirus Infections

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT06491446 2026-02-18

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Phase 1/2 Active not recruiting

Sexually Transmitted Diseases, Papillomavirus Infections

NCT04607850 2025-08-28

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

Phase 1/2 Completed

Papillomavirus Infections

NCT05592626 2025-07-09

START-001

Phase 1/2 Recruiting

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Abdominal Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms, Urogenital Neoplasms, Vulvar Diseases, Vulvar Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Epstein-Barr Virus Infections, Papillomavirus Infections, Microsatellite Instability, Small Cell Lung Carcinoma

NCT04724980 2025-06-11

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Phase 1/2 Active not recruiting

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT03610581 2025-02-04

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Phase 1/2 Terminated

9 enrolled 13 charts

Papillomavirus Infections

NCT06797986 2025-01-29

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects with HPV Positive HNSCC.

Phase 1/2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT06672653 2024-11-04

PREPAP

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT02535104 2018-06-06

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Phase 1/2 Completed

Condylomata Acuminata, Sexually Transmitted Diseases, Papillomavirus Infections

NCT01532102 2018-05-30

Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts

Phase 1/2 Completed

Condylomata Acuminata, Papillomavirus Infections